» Articles » PMID: 315930

Serum and Sputum Antibiotic Levels After Ampicillin, Amoxycillin and Bacampicillin Chronic Bronchitis Patients

Overview
Journal Infection
Date 1979 Jan 1
PMID 315930
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Serum and sputum concentrations of ampicillin or amoxycillin were measured in patients admitted to hospital for acute exacerbations of chronic bronchitis with purulent sputum. Mean peak serum levels of nearly 12 mg/l were found after 1600 mg bacampicillin (mean peak level in sputum 0.85 mg/l). The serum and sputum concentrations after 750 mg amoxycillin and 800 mg bacampicillin were comparable (mean peak serum levels approximately 9.5 mg/l, sputum concentrations 0.4 to 0.5 mg/l) although the drugs were not given in equimolar doses. Results after 1000 mg ampicillin by mouth were less satisfactory (mean peak serum level 7.8 mg/l) and only 0.25 mg/l was attained in the sputum. Minimum inhibitory concentrations of ampicillin and amoxycillin were measured for 177 Haemophilus influenzae strains. Most of the ampicillin MIC values were between 0.125 and 0.5 mg/l but more of the strains required 0.5 mg/l of amoxycillin. The amoxycillin MIC values were often one or two dilutions higher than those of ampicillin (p less than 0.001).

Citing Articles

Systematic review: the bioavailability of orally administered antibiotics during the initial phase of a systemic infection in non-ICU patients.

van den Broek A, Prins J, Visser C, Van Hest R BMC Infect Dis. 2021; 21(1):285.

PMID: 33743592 PMC: 7981967. DOI: 10.1186/s12879-021-05919-w.


A copper-dependent compound restores ampicillin sensitivity in multidrug-resistant Staphylococcus aureus.

Crawford C, Dalecki A, Perez M, Schaaf K, Wolschendorf F, Kutsch O Sci Rep. 2020; 10(1):8955.

PMID: 32488067 PMC: 7265353. DOI: 10.1038/s41598-020-65978-y.


Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.

Brusse-Keizer M, VanderValk P, van der Zanden R, Nijdam L, van der Palen J, Hendrix R Int J Chron Obstruct Pulmon Dis. 2015; 10:455-61.

PMID: 25767383 PMC: 4354398. DOI: 10.2147/COPD.S70355.


Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.

Kratzer C, Graninger W, Macfelda K, Buxbaum A, Georgopoulos A Wien Klin Wochenschr. 2007; 119(9-10):297-302.

PMID: 17571234 DOI: 10.1007/s00508-007-0784-5.


Bacampicillin treatment of pneumococcal pneumonia in high risk patients.

Campbell S Bull N Y Acad Med. 1983; 59(5):497-504.

PMID: 6576835 PMC: 1911653.


References
1.
Davies B, MAESEN F, Brombacher P, Sjovall J . Twice daily dosage of bacampicillin in chronic bronchitis. A double-blind study. Scand J Respir Dis. 1978; 59(5):249-56. View

2.
Ingold A . Sputum and serum levels of amoxycillin in chronic bronchial infections. Br J Dis Chest. 1975; 69:211-6. DOI: 10.1016/0007-0971(75)90082-0. View

3.
HANSMAN D . Haemophilus influenzae type B resistant to tetracycline isolated from children with meningitis. Lancet. 1975; 2(7941):893-6. DOI: 10.1016/s0140-6736(75)92128-5. View

4.
MAESEN F, BEEUWKES H, Davies B, BUYTENDIJK H, Brombacher P, Wessman J . Bacampicillin in acute exacerbations of chronic bronchitis--a dose-range study. J Antimicrob Chemother. 1976; 2(3):279-85. DOI: 10.1093/jac/2.3.279. View

5.
May J, Davies J . Resistance of Haemophilus influenzae to trimethoprim. Br Med J. 1972; 3(5823):376-7. PMC: 1785450. DOI: 10.1136/bmj.3.5823.376. View